Johnson & Johnson Highlights MedTech and Multiple Myeloma Milestones
Johnson & Johnson says it delivered an Ottava MedTech innovation and reported positive Phase 3 results in multiple myeloma during the third quarter.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.